Diabetes Care, Vol 20, Issue 2 198-201, Copyright © 1997 by American Diabetes Association

ARTICLES

The classification of diabetes by clinical and C-peptide criteria. A prospective population-based study

FJ Service, RA Rizza, BR Zimmerman, PJ Dyck, PC O'Brien and LJ Melton
Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota 55905, USA.

OBJECTIVE: To evaluate both the concordance in the classification of diabetes by clinical and C-peptide criteria and, prospectively, the consistency of the classification by C-peptide. RESEARCH DESIGN AND METHODS: Individuals with diabetes who were enlisted in the prospective epidemiological study of diabetic neuropathy (Rochester Diabetic Neuropathy Study [RDNS]) were classified clinically by National Diabetes Data Group (NDDG) criteria to IDDM and NIDDM at entry to the study. In addition, C-peptide response to 1 mg glucagon was measured at entry for the classification to IDDM (basal C-peptide, < 0.17 pmol/ml; increment above basal, < 0.07 pmol/ml) and NIDDM (all other responses) and for concordance with the clinical classification made. The consistency of the C-peptide response was assessed every 2 years for up to 8 years. RESULTS: Among 346 individuals with diabetes, 84 were classified as IDDM and 262 as NIDDM by clinical algorithm. COncordance with the C-peptide response occurred in 89% of the patients and remained consistent during 8 years of follow-up. Among the 37 patients with discordant clinical and C-peptide classification, those considered clinically to have NIDDM had a consistent IDDM C-peptide response during follow-up, and most of those considered to have IDDM clinically eventually showed an IDDM C-peptide response during follow-up. CONCLUSIONS: Clinical criteria for the classification of diabetes are highly correlated with the assessment of insulin secretory reserve. A small number of individuals considered to have NIDDM clinically or by C-peptide have or develop an IDDM peptide response.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Rodriguez Cabaleiro, D. Stockl, J. M. Kaufman, T. Fiers, and L. M. Thienpont Feasibility of Standardization of Serum C-Peptide Immunoassays with Isotope-Dilution Liquid Chromatography-Tandem Mass Spectrometry Clin. Chem., June 1, 2006; 52(6): 1193 - 1196. [Abstract] [Full Text] [PDF]

				E. S Siraj, S. S. K Reddy, W. A Scherbaum, J. Abdulkadir, J. P Hammel, and C. Faiman Basal and Postglucagon C-Peptide Levels in Ethiopians with Diabetes Diabetes Care, March 1, 2002; 25(3): 453 - 457. [Abstract] [Full Text] [PDF]

				W.B. CHAN, J.C.N. CHAN, C.C. CHOW, V.T.F. YEUNG, W.Y. SO, J.K.Y. LI, G.T.C. KO, R.C.W. MA, and C.S. COCKRAM Glycaemic control in type 2 diabetes: the impact of body weight, {beta}-cell function and patient education QJM, March 1, 2000; 93(3): 183 - 190. [Abstract] [Full Text] [PDF]

				A. Balasubramanyam, J. W. Zern, D. J. Hyman, and V. Pavlik New Profiles of Diabetic Ketoacidosis: Type 1 vs Type 2 Diabetes and the Effect of Ethnicity Arch Intern Med, October 25, 1999; 159(19): 2317 - 2322. [Abstract] [Full Text] [PDF]